The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development
With over 55 million people diagnosed worldwide, Alzheimer's disease presents a significant public health challenge,…
Danielle Pillsbury2024 年 4 月 29 日
Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin
Physiologically-based pharmacokinetic models combine knowledge about physiology, drug product properties, such as physicochemical parameters, absorption,…
Jim Gallagher2024 年 4 月 26 日
用 Simcyp™ 探索内源性生物标记物的世界！
Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling…
Certara2024 年 4 月 26 日
Latest PBPK Modeling Platform Advances Drug Development
In the ever-evolving pharmaceutical landscape, advancing drug development requires innovative tools that seamlessly integrate science…
Certara2024 年 4 月 23 日
Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb
Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies,…
Certara2024 年 4 月 18 日
The Challenges and Opportunities of Rare Disease Drug Development
This whitepaper by drug development experts reflect on some of these challenges and opportunities in…
Simona Colucci2024 年 4 月 18 日
